Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Catalent Inc (CTLT)

Catalent Inc (CTLT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,011,884
  • Shares Outstanding, K 146,416
  • Annual Sales, $ 2,518 M
  • Annual Income, $ 137,400 K
  • 60-Month Beta 1.70
  • Price/Sales 3.25
  • Price/Cash Flow 16.91
  • Price/Book 4.77

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate 0.50
  • Number of Estimates 4
  • High Estimate 0.55
  • Low Estimate 0.46
  • Prior Year 0.45
  • Growth Rate Est. (year over year) +11.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
54.55 +1.10%
on 02/26/20
68.78 -19.82%
on 02/03/20
-6.43 (-10.44%)
since 01/24/20
3-Month
50.41 +9.40%
on 12/03/19
68.78 -19.82%
on 02/03/20
+2.48 (+4.71%)
since 11/26/19
52-Week
39.09 +41.08%
on 04/12/19
68.78 -19.82%
on 02/03/20
+12.29 (+28.67%)
since 02/26/19

Most Recent Stories

More News
Catalent Announces Upsizing and Pricing of Private Offering of Senior Unsecured Notes Due 2028

Catalent, Inc. ("Catalent") (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer...

CTLT : 55.31 (+1.08%)
Catalent Announces Launch of Private Offering of EUR450 Million of Senior Unsecured Notes Due 2028

Catalent, Inc. ("Catalent") (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer...

CTLT : 55.31 (+1.08%)
Catalent, Inc. to Present at the 9th Annual SVB Leerink Global Healthcare Conference

Catalent, Inc. (NYSE:CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, today...

CTLT : 55.31 (+1.08%)
Revance Therapeu is Among the Companies in the Pharmaceuticals Industry with the Best Relative Performance (RVNC , LCI , CTLT , NKTR , MYL )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

CTLT : 55.31 (+1.08%)
LCI : 9.00 (-0.67%)
RVNC : 25.00 (+0.97%)
Catalent Inc Shares Up 20.4% Since SmarTrend's Buy Recommendation (CTLT)

SmarTrend identified an Uptrend for Catalent Inc (NYSE:CTLT) on October 28th, 2019 at $49.89. In approximately 4 months, Catalent Inc has returned 20.40% as of today's recent price of $60.07.

CTLT : 55.31 (+1.08%)
Top 5 Companies in the Pharmaceuticals Industry with the Best Relative Performance (HZNP , MNK , CTLT , AGN , BMY )

Here are the top 5 stocks in the Pharmaceuticals industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

CTLT : 55.31 (+1.08%)
HZNP : 35.15 (+3.75%)
MNK : 4.18 (-12.00%)
Catalent Completes Acquisition of MaSTherCell

Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products,...

CTLT : 55.31 (+1.08%)
SmarTrend Watching for Potential Rebound in Shares of Catalent Inc After 2.09% Loss

Catalent Inc (NYSE:CTLT) traded in a range yesterday that spanned from a low of $57.56 to a high of $58.90. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $58.60...

CTLT : 55.31 (+1.08%)
Global Biopharmaceutical Analytical Testing Services Market 2020-2024 | Evolving Opportunities with Boston Analytical and Catalent Inc. | Technavio

The biopharmaceutical analytical testing services market is poised to grow by USD 1.18 billion during 2020-2024, progressing at a CAGR of over 9% during the forecast period. Request free sample pages

CTLT : 55.31 (+1.08%)
Catalent, Inc. Announces Pricing of Public Offering of Common Stock

Catalent, Inc. ("Catalent") (NYSE:CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health...

CTLT : 55.31 (+1.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade CTLT with:

Business Summary

Catalent, Inc. provides advanced delivery technologies and development solutions for drugs, biologics and consumer health products. It operates through Oral Technologies, Medication Delivery Solutions, and Development & Clinical Services. The Oral Technologies segment address the full diversity of the...

See More

Key Turning Points

2nd Resistance Point 57.60
1st Resistance Point 56.16
Last Price 55.31
1st Support Level 53.92
2nd Support Level 53.12

See More

52-Week High 68.78
Fibonacci 61.8% 57.44
Last Price 55.31
Fibonacci 50% 53.93
Fibonacci 38.2% 50.43
52-Week Low 39.09

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar